Pinnacle is committed to maintaining a quality assurance program that complies with applicable federal (21 CFR 1271 and 21 CFR 210/211) and state regulations and implements industry best-practices and standards. Pinnacle is registered with the Food and Drug Administration (FDA), accredited by the American Association of Tissue Banks (AATB), registered with Health Canada for Human Cells, Tissue and Organs for Transplantation (CTO) and other international regulating authorities, and maintains all applicable state licenses.